Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Molecular Analysis of Microphthalmia/Anophthalmia Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for qualified medical advice, visits or professional assistance with a genuine dr.. We are not doctors. Always consult your mD about Molecular Analysis of Microphthalmia/Anophthalmia conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Molecular Analysis of Microphthalmia/Anophthalmia Clinical research trials and Molecular Analysis of Microphthalmia/Anophthalmia medical trials take place in many of places throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectiveness of new does drugs. The purpose of the studies / projects is to solve specific human healthcare questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to find cures for all varieties of conditions, like Molecular Analysis of Microphthalmia/Anophthalmia. Molecular Analysis of Microphthalmia/Anophthalmia Clinical Trials and other clinical trials allow for volunteers to have health treatment options before they are available to the masses. Many times the human subjects acquire professional assistance for free of charge, and sometimes they are compensated for their time. Occasionally there is a cost for a Molecular Analysis of Microphthalmia/Anophthalmia clinical trial. Test subjects typically obtain the finest healthcare available for their Molecular Analysis of Microphthalmia/Anophthalmia condition. Dangers are a reality, nevertheless, and might include additional or frequent doctor trips, medical dangers (possibly life-jeopardising), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials patients.

Home > "M" Clinical Trials Conditions > Molecular Analysis of Microphthalmia/Anophthalmia

Molecular Analysis of Microphthalmia/Anophthalmia



Molecular Analysis of Microphthalmia/Anophthalmia

For Condition: Anophthalmos
Status: Recruiting
Sponsor(s): National Human Genome Research Institute (NHGRI) ,
Synopsis: This study will try to learn more about the genetic cause and symptoms of microphthalmia (small eyes) or anophthalmia (absence of one or both eyes). Patients with microphthalmia or anophthalmia with mental retardation may be eligible for this study. Patients' parents and siblings will also be included for genetic studies. Patients may participate in both the clinical and laboratory parts of the study or just the laboratory part, as described below: Laboratory The laboratory study consists of DNA analysis to determine the genetic cause of microphthalmia/anophthalmia. The DNA sample is obtained using one of the following methods: -Blood draw - for young children, a numbing cream is applied to the skin before the needlestick to decrease the pain -Skin biopsy - a small piece of skin (about 1/8-inch in diameter) is removed surgically after the area has been numbed with an anesthetic -Cotton swab - a specimen is collected from inside the cheek using a cotton swab. This is done only for patients who cannot provide a blood or skin sample. -Prenatal sample - If, in the case of newborns, specimens are left from prenatal testing, these can be used instead of a blood sample. Some patients may have a permanent cell line grown from the blood or skin sample for use in future research tests. Clinical For the clinical study, participants undergo some or all of the following procedures at the NIH Clinical Center: -Physical examination -Clinical photographs, X-rays, blood tests -Magnetic resonance imaging (MRI) scan of the brain - a diagnostic procedure that uses a magnetic field and radio waves instead of X-rays to produce images of the brain
Details: We are interested in identifying the underlying mechanistic pathway of microphthalmia/anophthalmia with mental retardation. This a heterogeneous group that includes Lenz dysplasia/microphthalmia with associated anomalies (MAA) OMIM #309700, and Clinical anophthalmos (ANOP1) OMIM #301590 and other as yet to be defined malformations of the globe. To date, the causative molecular defects leading to these conditions have not been identified. To further delineate these conditions, we will study families with these features through a combined clinical and molecular approach. Specimens will be collected and evaluated in the laboratory by linkage analysis, physical mapping, candidate gene characterization, mutation screening, and cell biologic studies of normal and mutant proteins.
Eligibility:
Study Type:
  Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA: Affected individuals with unilateral or bilateral microphthalmia/anophthalmia from families with an X-linked mode of transmission. Parents and siblings will be included for linkage analysis. Unaffected non-transmitting parents may be included to clarify haplotype status. In addition, families with X-linked microphthalmia/anophthalmia with associated anomalies such as Lenz dysplasia and other X-linked recessive microphthalmia/anopthalmia syndrome will be analyzed to determine if these conditions are allelic. In latter stages of the study, a limited number of sporadic cases of microphthalmia with or without mental retardation may be considered for the study, along with parents and unaffected siblings. Unaffected subjects may also be enrolled if needed for controls. EXCLUSION CRITERIA: If the patient has microphthalmia/anophthalmia with autosomal recessive or autosomal dominant pattern of inheritance, the family will be excluded.
Total Enrollment: 200

Location and Contact Information:

National Human Genome Research Institute (NHGRI) *Recruiting*
Bethesda,  Maryland,  20892
United States
Recruiting Patient  and Public Liaison Office 1-800-411-1222


Additional Information:
Study ID Numbers:
  010094;  01-HG-0094
Study Start Date: February 22, 2001
Record last reviewed: January 29, 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00011843

Other Anophthalmos Studies:
1. Molecular Analysis of Microphthalmia/Anophthalmia

Related Studies:

Other Anophthalmos Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials

Molecular Analysis of Microphthalmia/Anophthalmia

Modify your Search

  Other Anophthalmos Clinical Trials
  Other Maryland Clinical Trials
  Other Bethesda Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103